August James Troendle M.D.
Net Worth
Last updated:
What is August James Troendle M.D. net worth?
The estimated net worth of Dr. August James Troendle M.D. is at least $1,168,075,316 as of 28 May 2024. He owns shares worth $308,997,632 as insider, has earned $848,907,684 from insider trading and has received compensation worth at least $10,170,000 in Medpace Holdings, Inc..
What is the salary of August James Troendle M.D.?
Dr. August James Troendle M.D. salary is $1,130,000 per year as Chairman & Chief Executive Officer in Medpace Holdings, Inc..
How old is August James Troendle M.D.?
Dr. August James Troendle M.D. is 69 years old, born in 1956.
What stocks does August James Troendle M.D. currently own?
As insider, Dr. August James Troendle M.D. owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Medpace Holdings, Inc. (MEDP) | Chairman & Chief Executive Officer | 654,656 | $472 | $308,997,632 |
What does Medpace Holdings, Inc. do?
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
August James Troendle M.D. insider trading
Medpace Holdings, Inc.
Dr. August James Troendle M.D. has made 198 insider trades between 2016-2024, according to the Form 4 filled with the SEC. Most recently he sold 5,695 units of MEDP stock worth $2,252,316 on 28 May 2024.
The largest trade he's ever made was exercising 869,565 units of MEDP stock on 16 Aug 2016. As of 28 May 2024 he still owns at least 654,656 units of MEDP stock.
Medpace Holdings key executives
Medpace Holdings, Inc. executives and other stock owners filed with the SEC:
- Dr. August James Troendle M.D. (69) Chairman & Chief Executive Officer
- Mr. Jesse J. Geiger BBA, CPA (51) Pres
- Mr. Stephen P. Ewald (56) Chief Compliance Officer, Gen. Counsel & Corporation Sec.
- Ms. Susan E. Burwig (62) Executive Vice President of Operations